Abate AS Industries Fair Value
Abate AS Industries (ABATEAS) average fair value is ₹8.07 across 5 valuation models — P/E Based Valuation, P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, Benjamin Graham Number, vs a current market price of ₹9.57 (-15.63%), fair value range ₹5.66–₹11.44. Check Abate AS Industries market worth to track the company's total market size over time.
Fair Value Analysis Export
ABATEAS Fair Value vs Current Price — Valuation Summary
ABATEAS average fair value, fair value range, price gap and valuation status across 5 models: P/E Based Valuation, P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, Benjamin Graham Number. For live price and a broader fundamental view, visit ABATEAS stock price BSE.
P/E Based Valuation
P/B Based Valuation
Price-to-Sales Valuation
Asset-Based Valuation
Benjamin Graham Number
ABATEAS Fair Value Analysis — Data Sources & Coverage
Abate AS Industries financial data sources, valuation methods applied and sector benchmarks used — 2026 financial year.
Available Data Sources: Financial statements, balance sheet data , sector comparisons.
Data Currency: Financial data is from the current year (2026).
ABATEAS vs Healthcare Services Sector Peers — P/E, P/B & Market Cap
Abate AS Industries P/E ratio, P/B ratio and market capitalisation vs Healthcare Services sector peers — relative valuation comparison.
| Company | Symbol | P/E Ratio | P/B Ratio | Market Cap (₹ Cr) |
|---|---|---|---|---|
| Apollo Hospitals | APOLLOHOSP | 63.8 | 13.49 | ₹126,904 |
| Jupiter Life Line Hospit… | JLHL | 44.49 | 5.79 | ₹8,320 |
| Dr. Agarwal's Health Care | AGARWALEYE | 93.81 | 7.78 | ₹15,554 |
| Suraksha Diagnostic | SURAKSHA | 40.64 | 5.71 | ₹1,356 |
| Gujarat Kidney and Super… | GKSL | 62.21 | 4.14 | ₹1,045 |
Important Disclaimer
This fair value analysis is for informational and educational purposes only. The calculations are based on publicly available financial data and various valuation methodologies.
This analysis does not constitute investment advice, recommendations, or suggestions to buy, sell, or hold any securities. Past performance and financial data do not guarantee future results.
Please conduct your own research and consult with qualified financial advisors before making any investment decisions. Market conditions, company fundamentals, and other factors can significantly impact actual stock performance.